Facing high costs or long waitlists for CAR-T cell therapy? Our new guide explores clinical pathways, costs, and top-tier hospitals for international patients navigating Medical Tourism China.
Note: As a medical concierge provider, MedBridgeNZ coordinates logistics and specialist access; we do not provide direct medical services.
Read the full guide here: https://zurl.co/ysL81
#Oncology #CART #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism

CAR-T therapy in China for international patients: Cost & Hospital Guide
Home > Blog > Advanced Therapies & TechnologyKey Takeaways • Cost Efficiency: While commercial CAR-T therapy in Western markets often exceeds $600,000, approved commercial pathways in China average $160,000 to $220,000. Patients qualifying for Investigator-Initiated Trials (IITs) may only bear logistical and ancillary medical costs, typically ranging from $40,000 to $60,000. • Expedited Timelines: Advanced cellular manufacturing platforms in select Chinese facilities aim to compress vein-to-vein




